Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,365.00
Bid: 4,365.00
Ask: 4,380.00
Change: 0.00 (0.00%)
Spread: 15.00 (0.344%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,365.00
CWK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company
3rd Nov 20222:55 pmRNSHolding(s) in Company
14th Oct 202211:33 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Oct 202211:31 amRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Oct 20227:00 amRNSTotal Voting Rights
15th Sep 202211:13 amRNSDirector/PDMR Shareholding
15th Sep 202211:12 amRNSDirector/PDMR Shareholding
13th Sep 20223:46 pmRNSDirector/PDMR Shareholding
13th Sep 20223:46 pmRNSDirector/PDMR Shareholding
13th Sep 20223:43 pmRNSDirector/PDMR Shareholding
13th Sep 20223:42 pmRNSDirector/PDMR Shareholding
9th Sep 202211:14 amRNSDirector/PDMR Shareholding
1st Sep 202210:00 amRNSTotal Voting Rights
31st Aug 20221:40 pmRNSTotal Voting Rights
31st Aug 20221:38 pmRNSAdditional Listing
15th Aug 20228:51 amRNSDirectorship
10th Aug 20222:49 pmRNSDirector/PDMR Shareholding
2nd Aug 20224:16 pmRNSHolding(s) in Company
1st Aug 20224:41 pmRNSPoll Result for 2022 Annual General Meeting
1st Aug 20224:15 pmRNSTotal Voting Rights
1st Aug 20227:00 amRNSFirst quarter trading statement
29th Jul 20221:02 pmRNSDividend Declaration
5th Jul 20223:03 pmRNSDirector/PDMR Shareholding
5th Jul 20223:02 pmRNSDirector/PDMR Shareholding
5th Jul 20223:00 pmRNSDirector/PDMR Shareholding
5th Jul 20222:59 pmRNSDirector/PDMR Shareholding
5th Jul 20222:58 pmRNSDirector/PDMR Shareholding
4th Jul 20221:25 pmRNSTotal Voting Rights
4th Jul 202211:12 amRNSDirector/PDMR Shareholding
4th Jul 202211:10 amRNSDirector/PDMR Shareholding
4th Jul 202211:05 amRNSDirector/PDMR Shareholding
4th Jul 202211:01 amRNSDirector/PDMR Shareholding
28th Jun 20229:44 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.